BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11263941)

  • 1. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review.
    Isaacs RJ; Hunter W; Clark K
    Gynecol Oncol; 2001 Mar; 80(3):405-8. PubMed ID: 11263941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen and pregnancy.
    Barthelmes L; Gateley CA
    Breast; 2004 Dec; 13(6):446-51. PubMed ID: 15563850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature.
    Meyer-Wittkopf M; Barth H; Emons G; Schmidt S
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):62-6. PubMed ID: 11489228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.
    Ohara N; Kobayashi A
    J Obstet Gynaecol; 2002 Sep; 22(5):572-3. PubMed ID: 12521448
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature.
    Koca T; Akgun Z; Yucel SB; Dag NZ; Teomete M
    J Oncol Pharm Pract; 2011 Dec; 17(4):440-3. PubMed ID: 20858636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
    Kerr JR
    Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
    Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
    Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
    Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
    Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature.
    Hill N; Madarnas Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):265-8. PubMed ID: 21541703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer.
    Tiezzi DG; de Andrade JM; Marana HR; Garieri AP; de Paula Philbert PM
    Breast J; 2009; 15(4):333-8. PubMed ID: 19496783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA; Palmer DH; Moon S; Rea DW
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pregnancy-associated breast cancer.
    Janni W; Hepp P; Nestle-Kraemling C; Salmen J; Rack B; Genss E; Schindlbeck C; Friese K
    Expert Opin Pharmacother; 2009 Oct; 10(14):2259-67. PubMed ID: 19663633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
    Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
    Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.